HCPCS Level II code J0802 denotes an injection of corticotropin (ani), up to 40 units, used in clinical settings where adrenocorticotropic hormone preparations are indicated. This code is important nationally because it identifies a specific injectable biologic product for billing, coverage determinations, and utilization tracking across outpatient and office-based care. Payers commonly engaged in coverage and payment decisions for this code include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will find a concise briefing on the clinical context for corticotropin injections, the typical sites of service where J0802 claims arise, and the payer landscape affecting coverage and reimbursement. The publication summarizes benchmark considerations, common billing practices, and policy trends relevant to injectable biologics coded via HCPCS Level II. Where available, the analysis highlights reimbursement benchmarks and coding guidance that impact billing workflows and prior authorization requirements. Data not available in the input is noted where applicable.